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Hereditary episodic diseases are a remarkable group of phenotypes ranging from rare muscle
diseases and movement disorders to more common forms of epilepsy and migraine headache.
Despite the fact that affected individuals carry the relevant mutation for their entire life, attacks
occur intermittently. Patients are often completely normal between attacks.
Although on the surface these disorders appear quite different, striking similarities exist across
all these diseases (Figure 1). In addition to these disorders being episodic, factors that can pre-
cipitate attacks overlap significantly among these disorders. Stress is the most uniform in this
regard, although the specific pathway is not understood. Sleep deprivation is another—however,
it is unclear whether this is simply one form of stress or whether something specific about sleep is
required for maintaining homeostasis of membrane excitability in these disorders.
Certain dietary factors can lower the threshold for having an attack and include manipulations
of dietary potassium, caffeine, and alcohol. Therapies that benefit patients in prevention of attacks
also overlap. For example, carbonic anhydrase inhibitors decrease attack frequency for many
patients with periodic paralysis, episodic ataxia, and migraine. Some anticonvulsant drugs have
carbonic anhydrase inhibitory activity, although whether this activity contributes to antiseizure
effects is unknown. This similarity among many different episodic diseases suggests that carbonic
anhydrase inhibition may have an antiepileptic effect. Anticonvulsant drugs are also very effective
in treating hyperexcitability phenotypes in many patients (e.g., seizures, paroxysmal dyskinesia,
and myotonia).
The natural history of these disorders is also similar—they often come on in childhood, worsen
through adolescence and young-adult life, and improve (and sometimes completely resolve) in
middle- and late-adult life. The reason for this pattern is unknown. Finally, for conditions for
which a clinical electrophysiological test is available, hyperexcitable phenotypes can sometimes be
seen (Figure 2). These phenotypes includemyotonia on electromyograms, cardiac arrhythmias on
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Figure 1
Many different electrical and episodic diseases affect skeletal muscle, the brain, and the heart. Although quite
different in some ways, these disorders share similarities such as their episodic nature, precipitating factors,
natural history, apparent hormonal influences, and therapeutic responses. Abbreviations: AHC, alternating
hemiplegia of childhood; CVS, cyclic vomiting syndrome; LQTS, long-QT syndrome.
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Figure 2
The physiologies of muscle, nerve, and heart tissues are somewhat different. Shown are recordings from
(a) skeletal muscle [electromyogram (EMG)], (b) the heart [electrocardiogram (ECG)], and (c) the brain
[electroencephalogram (EEG)]. Also shown are physiological abnormalities seen in some periodic paralyses
(myotonia on EMG), in cardiac arrhythmias (ventricular tachycardia on ECG), and in epilepsy (focal
electrographic seizure on EEG). These disorders share the abnormal physiological phenomenon of highly
repetitive, organized, but abnormal activity manifest clinically as myotonia, ventricular tachycardia, or
seizure. Adapted with permission from Reference 8.
electrocardiograms, and seizures on electroencephalograms. Although the physiologies of muscle,
the heart, and the brain are somewhat different, all these electrophysiological findings represent
abnormal, but highly organized, repetitive firing of the respective tissues.
Studies of a rare group of muscle diseases, the familial periodic paralyses, established the ge-
netic paradigm for these episodic disorders. The first reports of channel mutations in episodic
or electrical diseases were for hyperkalemic periodic paralysis and paramyotonia congenita
(1–4). These developments led us to propose the term channelopathies to connote disorders
of ion channels resulting from genetic mutations (5). With the cloning of the first human
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Figure 3
Voltage-gated cation channels were the first channels to be implicated in electrical disorders. Systematic
study of the periodic paralyses and nondystrophic myotonias led to identification of mutations in voltage-
gated sodium and calcium channels and, later, voltage-gated chloride (anion) and inwardly rectifying
potassium channels. Shown here is a graphical representation of the homologous sodium (NaCh), calcium
(CaCh), and potassium (KCh) channels first defined in this fascinating group of muscle diseases. KChs must
tetramerize (denoted by ×4) to form functional channels. Subsequent work from many labs has shown that
mutations in other genes from this family can give rise not only to muscle diseases, but also to epilepsy,
migraine headache, episodic movement disorders, cardiac dysrhythmias, and peripheral sensory/pain
syndromes. The symptom complex is predictably dependent on the expression pattern of the specific channel
gene. Adapted with permission from Reference 8.
mutation, we had predicted that mutations in homologous genes were outstanding candidates
for hereditary forms of epilepsy, cardiac arrhythmias, and peripheral nerve disorders (3). Sub-
sequent work by our group and others has indeed shown this prediction to be true (Figure 3).
There are now many reports of ion channel genes responsible for periodic paralyses and nondys-
trophic myotonias; episodic ataxias; epilepsies; hyperekplexia; familial hemiplegic migraine; and
sensory syndromes like congenital insensitivity to pain, erythromelalgia, and paroxysmal itch
(6, 7).
The term channelopathy has been misused by many to describe any bizarre disorder with
fluctuating symptoms. We suggest that channelopathy should be reserved as a term to describe
disorders in which there is molecular and genetic understanding of abnormal channel function.
Clearly, all episodic disorders of the nervous system and heart ultimately result in abnormal
electrical signaling.We suggest the termprimary channelopathy for those cases inwhichmutations
occur in the primary determinants ofmembrane excitability (e.g., voltage-gated channels, inwardly
rectifying ion channels, ligand-gated channels, ion transporters, and ion exchangers) (Figure 4). In
this special section of reviews, special attention is paid to classifying episodic or electrical disorders
into primary and secondary channelopathies, acquired channelopathies, and circuit-level disorders
that do not specifically affect ion channels but rather affect networks of neurons, with a net effect
of abnormal electrical signaling.
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Figure 4
Proposed classification scheme for electrical and episodic disorders.
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